ASHITA J TOLWANI, MD
Osteopathic Medicine at 19 St, Birmingham, AL

License number
Alabama 19424
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
619 19Th St SOUTH, Birmingham, AL 35233
Phone
(205) 934-6600
(205) 731-9701

Personal information

See more information about ASHITA J TOLWANI at radaris.com
Name
Address
Phone
Ashita Tolwani, age 54
2220 White Way, Hoover, AL 35226
Ashita J Tolwani, age 54
743 Ridge Way Cir, Birmingham, AL 35226
(205) 823-3016
Ashita J Tolwani, age 54
1516 10Th St S, Birmingham, AL 35205
Ashita J Tolwani
2220 White Way, Birmingham, AL 35226
(205) 823-0228

Organization information

See more information about ASHITA J TOLWANI at bizstanding.com

Uab Hospital - Ashita J Tolwani MD

1802 6 Ave S, Birmingham, AL 35233

Categories:
Nephrology Physicians & Surgeons
Phone:
(205) 934-9999 (Phone)


Ashita J Tolwani MD

1530 3 Ave S, Birmingham, AL 35294

Categories:
Nephrology Physicians & Surgeons
Phone:
(205) 934-4041 (Phone)

Professional information

See more information about ASHITA J TOLWANI at trustoria.com
Ashita Jiwat Tolwani Photo 1
Ashita Jiwat Tolwani, Birmingham AL

Ashita Jiwat Tolwani, Birmingham AL

Specialties:
Internal Medicine, Nephrology
Work:
University of AL Health Service Foundation-Pediatricss
1802 6Th Ave S, Birmingham, AL 35249 Birmingham Va Medical Center
700 19Th St S, Birmingham, AL 35233 University of AL Health Service Foundation-Pediatricss
2000 6Th Ave S, Birmingham, AL 35233
Education:
University of Alabama at Birmingham (1994)


Ashita J Tolwani Photo 2
Dr. Ashita J Tolwani - MD (Doctor of Medicine)

Dr. Ashita J Tolwani - MD (Doctor of Medicine)

Hospitals:
2000 6Th Ave S, Birmingham 35233
University of Alabama Hospital
1802 6Th Ave South, Birmingham 35233
2000 6Th Ave S, Birmingham 35233
University of Alabama Hospital
1802 6Th Ave South, Birmingham 35233
Education:
Medical Schools
University Of Alabama School Of Medicine
Graduated: 1994


Ashita Tolwani Photo 3
Process For Metabolic Control And High Solute Clearance And Solutions For Use Therein

Process For Metabolic Control And High Solute Clearance And Solutions For Use Therein

US Patent:
8147698, Apr 3, 2012
Filed:
Jan 20, 2011
Appl. No.:
13/010770
Inventors:
Ashita Tolwani - Birmingham AL, US
Rajesh Speer - Birmingham AL, US
Brenda Stofan - Birmingham AL, US
Assignee:
The UAB Research Foundation - Birmingham AL
International Classification:
B01D 61/24, A61K 33/14, A61K 33/00, A61K 31/19, A61M 1/14
US Classification:
210647, 210645, 210646, 604 401, 604 501, 424680, 514557, 514575
Abstract:
The present disclosure describes novel standardized citrate replacement fluid solutions and a standardized dialysate solution for use with CRRT methods. The standardized citrate replacement fluid solutions and standardized dialysate solutions do not require modification based on the clinical status of the individual patients. The use of the standardized solutions described herein offers significant advantages over the prior art solutions used in CRRT. The present disclosure describes superior metabolic and electrolyte control and significantly increased dialyzer patency in: (a) 24 intensive care unit (ICU) patients with ARF using a 0. 67% trisodium citrate replacement fluid solution, and (b) 32 ICU patients with ARF using a 0. 5% trisodium citrate replacement fluid solution. Both groups were treated with Bicarbonate-25 dialysate and achieved effluent rates of 35 mL/kg/hr.


Ashita Tolwani Photo 4
Process For Metabolic Control And High Solute Clearance And Solutions For Use Therein

Process For Metabolic Control And High Solute Clearance And Solutions For Use Therein

US Patent:
2007011, May 17, 2007
Filed:
Nov 14, 2005
Appl. No.:
11/273290
Inventors:
Ashita Tolwani - Birmingham AL, US
Rajesh Speer - Birmingham AL, US
Brenda Stofan - Homewood AL, US
International Classification:
A61K 33/14, A61K 31/19, A61K 33/00
US Classification:
424680000, 424717000, 514575000, 514557000
Abstract:
The present disclosure describes novel standardized citrate replacement fluid solutions and a standardized dialysate solution for use with CRRT methods. The standardized citrate replacement fluid solutions and standardized dialysate solutions do not require modification based on the clinical status of the individual patients. The use of the standardized solutions described herein offers significant advantages over the prior art solutions used in CRRT. The present disclosure describes superior metabolic and electrolyte control and significantly increased dialyzer patency in: (a) 24 intensive care unit (ICU) patients with ARF using a 0.67% trisodium citrate replacement fluid solution, and (b) 32 ICU patients with ARF using a 0.5% trisodium citrate replacement fluid solution. Both groups were treated with Bicarbonate-25 dialysate and achieved effluent rates of 35 mL/kg/hr.